Retrovirus-mediated tk gene therapy of implanted human breast cancer in nude mice under the regulation of Tet-On

Cancer Gene Therapy

Volumn 13, Issue 3, 2006, Pages 290-297

  Zeng, Z J ^a   Li, Z B ^a   Luo, S Q ^a   Hu, W X ^a  

^a Central South University   (China)

Author keywords

Gene regulation; Gene therapy; Human breast cancer; Suicide gene; Tet On

Indexed keywords

DOXYCYCLINE; GANCICLOVIR; MESSENGER RNA; RETROVIRUS VECTOR; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CANCER TISSUE; CANCER TRANSPLANTATION; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; EMBRYO; FEMALE; GENE EXPRESSION REGULATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; REPRESSOR GENE; SUICIDE GENE THERAPY; TUMOR NECROSIS; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; BYSTANDER EFFECT; CELL LINE, TUMOR; DOXYCYCLINE; FEMALE; GANCICLOVIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NECROSIS; PROTEIN SYNTHESIS INHIBITORS; RETROVIRIDAE; TETRACYCLINE; THYMIDINE KINASE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS; MUS MUSCULUS; SIMPLEXVIRUS;

EID: 32844463327     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700889     Document Type: Article

References (38)

1. Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S et al. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Cancer Gene Ther 2003; 10(5): 353-364.
2. Asklund T, Appelskog IB, Ammerpohl O, Langmoen IA, Dilber MS, Aints A et al. Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene. Exp Cell Res 2003; 284(2): 185-195.
3. Zhong Q, Kolls JK, Schwarzenberger P. Retrovirus molecular conjugates. A novel, high transduction efficiency, potentially safety-improved, gene transfer system. J Biol Chem 2001; 276(27): 24601-24607.
4. Bai Y, Soda Y, Izawa K, Tanabe T, Kang X, Tojo A et al. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector. Gene Therapy 2003; 10(17): 1446-1457.
5. Hillman GG, Slos P, Wang Y, Wright JL, Layer A, De Meyer M et al. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma. Cancer Gene Ther 2004; 11: 61-72.
6. Zabala M, Wang L, Hernandez-Alcoceba R, Hillen W, Qian C, Prieto J et al. Optimization of the Tet-On system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors. Cancer Res 2004; 64(8): 2799-2804.
7. Koponen JK, Kankkonen H, Kannasto J, Wirth T, Hillen W, Bujard H et al. Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Therapy 2003; 10(6): 459-466.
8. Tang Y, Jackson M, Qian K, Phillips MI. Hypoxia inducible double plasmid system for myocardial ischemia gene therapy. Hypertension 2002; 39(2, Part 2): 695-698.
9. Dalle B, Payen E, Beuzard Y. Modulation of transduced erythropoietin expression by iron. Exp Hematol 2000; 28(7): 760-764.
10. Worthington J, McCarthy HO, Barrett E, Adams C, Robson T, Hirst DG. Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment. J Gene Med 2004; 6(6): 673-680.
11. Schmeisser F, Donohue M, Weir JP. Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors. Hum Gene Ther 2002; 13(18): 2113-2124.
12. A-Mohammadi S, Hawkins RE. Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system. Gene therapy 1998; 5(1): 76-84.
13. Kim HJ, Gatz C, Hillen W, Jones TR. Tetracycline repressor-regulated gene repression in recombinant human cytomegalovirus. J Virol 1995; 69(4): 2565-2573.
14. Chtarto A, Bender HU, Hanemann CO, Kemp T, Lehtonen E, Levivier M et al. Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Therapy 2003; 10(1): 84-94.
15. Ginhoux F, Turbant S, Gross DA, Poupiot J, Marais T, Lone Y et al. HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. Mol Ther 2004; 10(2): 279-289.
16. Gimenez E, Lavado A, Giraldo P, Cozar P, Jeffery G, Montoliu L. A transgenic mouse model with inducible Tyrosinase gene expression using the tetracycline (Tet-On) system allows regulated rescue of abnormal chiasmatic projections found in albinism. Pigment Cell Res 2004; 17(4): 363-370.
17. Laposa RR, Henderson JT, Wells PG. Tetracycline-dependent regulation of formamidopyrimidine DNA glycosylase in transgenic mice conditionally reduces oxidative DNA damage in vivo. FASEB J 2003; 17(10): 1343-1345.
18. Hu WX, Zeng ZJ, Luo SQ, Chen Q. Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On. Chin Med J (Engl) 2004; 117(3): 434-439.
19. Sheridan PL, Bodner M, Lynn A, Phuong TK, DePolo NJ, de la Vega Jr DJ et al. Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer. Mol Ther 2000; 2(3): 262-275.
20. Jordan M, Wurm F. Transfection of adherent and suspended cells by calcium phosphate. Methods 2004; 33(2): 136-143.
21. Lake DE, Hudis CA. High-dose chemotherapy in breast cancer. Drugs 2004; 64(17): 1851-1860.
22. Kim KB, Eton O, East MJ, Hodges C, Papadopoulos NE, Grimm EA et al. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma. Cancer 2004; 101(3): 596-603.
23. Brade AM, Szmitko P, Ngo D, Liu FF, Klamut HJ. Heat-directed suicide gene therapy for breast cancer. Cancer Gene Ther 2003; 10(4): 294-301.
24. Kanazawa T, Mizukami H, Okada T, Hanazono Y, Kume A, Nishino H et al. Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice. Gene Therapy 2003; 10(1): 51-58.
25. Zerrouqi A, Rixe O, Ghoumari AM, Yarovoi SV, Mouawad R, Khayat D et al. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir. Cancer Gene Ther 1996; 3(6): 385-392.
26. Kashima Y, Miki T, Minami K, Seino S. Establishment of a tet-on gene expression system in glucose-responsive and -unresponsive MIN6 cells. Diabetes 2001; 50(Suppl): S133.
27. Mizuguchi H, Xu ZL, Sakurai F, Mayumi T, Hayakawa T. Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions. Hum Gene Ther 2003; 14(13): 1265-1277.
28. Kugawa F, Matsumoto K, Aoki M. Apoptosis-like cell death of human breast cancer cell line MCF-7 induced by buprenorphine hydrochloride. Life Sci 2004; 75(3): 287-299.
29. Simoes-Wust AP, Schurpf T, Hall J, Stahel RA, Zangemeister-Wittke U. Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide. Breast Cancer Res Treat 2002; 76(2): 157-166.
30. Harwell RM, Mull BB, Porter DC, Keyomarsi K. Activation of cyclin-dependent kinase 2 by full length and low molecular weight forms of cyclin E in breast cancer cells. J Biol Chem 2004; 279(13): 12695-12705.
31. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002; 347(20): 1566-1575.
32. Paulovich AG, Toczyski DP, Hartwell LH. When checkpoints fail. Cell 1997; 88(3): 315-321.
33. Agami R, Bernards R. Convergence of mitogenic and DNA damage signaling in the G1 phase of the cell cycle. Cancer Lett 2002; 177(2): 111-118.
34. Nagle DG, Zhou YD, Mora FD, Mohammed KA, Kim YP. Mechanism targeted discovery of antitumor marine natural products. Curr Med Chem 2004; 11(13): 1725-1756.
35. Tu LC, Melendy T, Beerman TA. DNA damage responses triggered by a highly cytotoxic monofunctional DNA alkylator, hedamycin, a pluramycin antitumor antibiotic. Mol Cancer Ther 2004; 3(5): 577-585.
36. Corban-Wilhelm H, Ehemann V, Becker G, Greulich D, Braun K, Debus J. Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy. Cancer Gene Ther 2004; 11: 208-214.
37. Wang Y, Hu JK, Krol A, Li YP, Li CY, Yuan F. Systemic dissemination of viral vectors during intratumoral injection. Mol Cancer Ther 2003; 2(11): 1233-1242.
38. Patil R, Chavez JB, Yee D. Inducible expression of herpes simplex virus thymidine kinase increases sensitivity to ganciclovir but does not enhance bystander effect in breast cancer cells. Breast Cancer Res Treat 2000; 62(2): 109-115.